110 related articles for article (PubMed ID: 6671627)
21. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
Fuller RW; Perry KW
J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
[TBL] [Abstract][Full Text] [Related]
22. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Batool F; Hasnat A; Haleem MA; Haleem DJ
Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
[TBL] [Abstract][Full Text] [Related]
23. Effects of taclamine (AY-22,214), a new psychoactive agent, on catecholamine and serotonin metabolism.
Pugsley TA; Lippmann W
Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):73-87. PubMed ID: 1156020
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
Hyttel J; Larsen JJ
J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
[TBL] [Abstract][Full Text] [Related]
25. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain.
Broch OJ
Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
Manias B; Taylor DA
Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
Arnt J; Christensen AV; Hyttel J
Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
[TBL] [Abstract][Full Text] [Related]
28. [Effect of trazodone (KB-831) and its metabolites on brain monoamines in rat].
Ikegami A; Maeda A; Hara H; Yamashita A; Sukamoto T; Ito K
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):145-54. PubMed ID: 2731805
[TBL] [Abstract][Full Text] [Related]
29. Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.
Sugrue MF
J Neural Transm; 1983; 57(4):281-95. PubMed ID: 6197507
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a cholinergic influence on catecholaminergic pathways terminating in the anterior and medial basal hypothalamus.
Morgan WW; Pfeil KA
Brain Res; 1979 Sep; 173(1):47-56. PubMed ID: 487084
[TBL] [Abstract][Full Text] [Related]
31. Influence of tramadol on neurotransmitter systems of the rat brain.
Frink MC; Hennies HH; Englberger W; Haurand M; Wilffert B
Arzneimittelforschung; 1996 Nov; 46(11):1029-36. PubMed ID: 8955860
[TBL] [Abstract][Full Text] [Related]
32. Monoamines (noradrenaline, dopamine, serotonin) in the rat cochlear nuclei: endogenous levels and turnover.
Cransac H; Cottet-Emard JM; Pequignot JM; Peyrin L
Hear Res; 1995 Oct; 90(1-2):65-71. PubMed ID: 8975006
[TBL] [Abstract][Full Text] [Related]
33. The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain.
Kafoe WF; Leonard BE
Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):389-91. PubMed ID: 4778631
[No Abstract] [Full Text] [Related]
34. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
[TBL] [Abstract][Full Text] [Related]
35. The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
Jenck F; Broekkamp CL; Van Delft AM
Eur J Pharmacol; 1990 Feb; 177(3):201-4. PubMed ID: 2107091
[TBL] [Abstract][Full Text] [Related]
36. Differential binding of antidepressants to noradrenaline and serotonin transport sites in central nerve endings.
Raiteri M; Del Carmine R; Cervoni AM; Levi G
Eur J Pharmacol; 1979 Aug; 57(4):407-16. PubMed ID: 488170
[TBL] [Abstract][Full Text] [Related]
37. [Influence of hypo- and hyperthyroidism on the turnover rate of noradrenaline, dopamine and serotonin in various rat cerebral structures].
Beley A; Beley P; Bralet J
Arch Int Physiol Biochim; 1975 Aug; 83(3):471-80. PubMed ID: 54127
[TBL] [Abstract][Full Text] [Related]
38. Effects of tremorine, physostigmine and tremor blocking drugs on brain monoamines.
Rogers KJ; Slater P
Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):68-72. PubMed ID: 5111328
[No Abstract] [Full Text] [Related]
39. Studies on the mechanism of wet dog shakes produced by carbachol in rats.
Turski WA; Czuczwar SJ; Turski L; Sieklucka-Dziuba M; Kleinrok Z
Pharmacology; 1984; 28(2):112-20. PubMed ID: 6200891
[TBL] [Abstract][Full Text] [Related]
40. Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats.
Tobe A; Egawa M; Nagai R
Jpn J Pharmacol; 1983 Aug; 33(4):775-84. PubMed ID: 6685201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
